These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 29656110)

  • 1. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
    Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
    Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
    Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
    J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
    Tso SC; Qi X; Gui WJ; Wu CY; Chuang JL; Wernstedt-Asterholm I; Morlock LK; Owens KR; Scherer PE; Williams NS; Tambar UK; Wynn RM; Chuang DT
    J Biol Chem; 2014 Feb; 289(7):4432-43. PubMed ID: 24356970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
    Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
    Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
    Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
    Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity.
    Capel F; Chabrier G; Pitois E; Rigaudière JP; Le Plenier S; Durand C; Jouve C; de Bandt JP; Cynober L; Moinard C; Morio B
    Br J Pharmacol; 2015 Oct; 172(20):4996-5008. PubMed ID: 26228176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
    Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
    Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
    Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
    Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
    Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
    J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific pyruvate dehydrogenase complex deficiency upregulates lipogenesis in adipose tissue and improves peripheral insulin sensitivity.
    Choi CS; Ghoshal P; Srinivasan M; Kim S; Cline G; Patel MS
    Lipids; 2010 Nov; 45(11):987-95. PubMed ID: 20835892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.
    Tso SC; Lou M; Wu CY; Gui WJ; Chuang JL; Morlock LK; Williams NS; Wynn RM; Qi X; Chuang DT
    J Med Chem; 2017 Feb; 60(3):1142-1150. PubMed ID: 28085286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
    Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
    J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
    Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
    J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
    Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
    J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
    Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
    PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization.
    Oh AR; Jeong Y; Yu J; Minh Tam DT; Kang JK; Jung YH; Im SS; Lee SB; Ryu D; Pajvani UB; Kim K
    Gastroenterology; 2023 Mar; 164(3):439-453. PubMed ID: 36402191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.